Together, we can turn groundbreaking concepts into impactful solutions.

Partnering with government, institutions, foundations, and nonprofits, we tackle pressing health challenges efficiently through the power of collaboration. Our experienced team of experts in science, medicine, engineering, and business, work alongside our partners to identify and nurture high-potential health innovation projects. 

The FDA has approved the first rapid hepatitis C virus test for the U.S. market that can be used in patient care settings. The test, which was validated in part by the NIH RADx Tech program with funding from CDC, can provide results in about one hour, meaning patients with a positive test can begin treatment right away. We're honored to have been a part of the journey behind this important milestone! 

Learn more about this game changer for hepatitis C diagnosis >

Moving Ideas Forward

  • Proven Processes: Streamlined methodologies that ensure efficiency and effectiveness. 
  • Hands-On Facilitation: Direct, personalized assistance through every step of the innovation process.
  • Global Network: Access to a world-class network of multidisciplinary experts ready to lend insights and expertise. 
  • Customized Tools: Tailored infrastructure, tools, and resources designed to fit the unique needs of your project. 
Partner with us

Where We Excel

  • Spotting highly promising projects.
  • Engaging the world’s leading experts.
  • Minimizing risk through our Deep Dive evaluation.
  • Maximizing speed and efficiency with the support of tailored tools.
  • Accelerating development through our road-tested process.
     
Learn about current projects

Our Impact

We have supported more than 1,200 innovator teams, evaluated more than 5,000 ideas, and helped develop more than a thousand healthcare innovations. Our efforts have resulted in:

  • 49% commercialization success rate.
  • $2 Billion in follow-on funding.
  • 1000+ healthcare innovations developed.
  • Touching millions of lives.
Find out more

Innovation Spotlight

The Role Rapid Acceleration of Diagnostics Tech Continues to Play in the Covid-19 Pandemic and Next Steps

The Role Rapid Acceleration of Diagnostics Tech Continues to Play in the Covid-19 Pandemic and Next Steps

Rapid Acceleration of Diagnostics (RADx) Tech is a National Institutes of Health (NIH)-funded program launched on 29 April 2020, to accelerate commercialization of novel lab-based, point-of-care, and home-based tests to diagnose infection with SARS-CoV-2, the virus that causes COVID-19. RADx Tech was implemented and coordinated by the Consortia for Improving Medicine with Innovation & Technology (CIMIT) in its role as the Coordinating Center for the Point-of-Care Technologies Research Network (POCTRN) in conjunction with the NIH’s National Institute of Biomedical Imaging and Bioengineering (NIBIB) and the four POCTRN Centers.

Read the full article in the Expert Review of Molecular Diagnostics >